Kirsten Grønbæk

Kirsten Grønbæk is a Professor at the University of Copenhagen and Chief Consultant Hematologist at Rigshospitalet. She is director of the “Danish Research Center for Precision Medicine in Blood Cancer”.  Kirsten Grønbæk has a longstanding interest in translational genetics and epigenetics of hematological cancers, with a main focus on the myelodysplastic syndrome (MDS). She runs a research lab specifically focused on the early stages of leukemogenesis.

In the clinics, she is responsible for treating patients with MDS and in particular those with hereditary myeloid cancers in the department of Hematology at the Copenhagen University Hospital, Rigshospitalet, and she co-chair the Nordic MDS group. Given the few options for cure in MDS, the primary goal of KG’s research and clinical work is to prevent or postpone the development of aggressive MDS in patients who are not eligible for curative treatment. Kirsten Grønbæk has several commissions of trust in Denmark and abroad, e.g. as Chair of the Danish Cancer Society’s Scientific Committee and in the executive board of the European Hematology Association.